新华制药：2025年度净利润约2.9亿元

Company Performance - Xinhua Pharmaceutical (SZ 000756) reported an annual performance for 2025 with an estimated revenue of approximately 8.755 billion yuan, representing a year-on-year increase of 3.41% [1] - The net profit attributable to shareholders of the listed company is approximately 290 million yuan, showing a year-on-year decrease of 38.32% [1] - The basic earnings per share is 0.42 yuan, which reflects a year-on-year decline of 39.13% [1]